Internist, hematologist-oncologist, transplant/CAR-T physician for lymphoma/CLL. Interest in clinical reasoning, risk, pragmatism.

Phoenix, AZ
Joined September 2015
I did not expect this piece to resonate with so many people. This is dedicated to all the clinicians in the trenches. thelancet.com/journals/lanha…
56
486
109
1,592
409,115
🎉 Our latest feature is out now! 🎉 We took a deep dive into the use of #MRD in hematologic malignancies with Elias Jabbour, MD, of @MDAndersonNews; @DrOlaLandgren of @SylvesterCancer; and @THilalMD of @MayoClinic. 📚 Read here! buff.ly/4fB37t0
3
6
870
Don’t miss @THilalMD speaking to me on #HemOnc Pulse podcast on MRD - @Blood_Cancers 👇👇👇👇👇👇
🙌 ICYMI: @THilalMD, of the @MayoClinic, joined @chadinabhan on "The HemOnc Pulse" last week to talk about #MRD and whether he uses it to make treatment decisions in #CLL. 🎧 buff.ly/3QQ0dpU
1
2
8
2,982
🙌 ICYMI: @THilalMD, of the @MayoClinic, joined @chadinabhan on "The HemOnc Pulse" last week to talk about #MRD and whether he uses it to make treatment decisions in #CLL. 🎧 buff.ly/3QQ0dpU
1
1
4
3,886
My new essay in @TheLancetHaem on clinical trials
4
22
6
70
15,930
Talal Hilal 🩺 retweeted
Come to see our work (poster 1916), a meta-analysis about the association of MRD with PFS in CLL. Thanks @THilalMD for the opportunity to work on this after my last year observership @ASH_hematology #ASH23 #CLLsm
1
3
55
3,769
Don't know who created this but very accurate
1
6
849
I'm also on call this weekend and it feels great! #ASH23 @AaronGoodman33
1
966
Not good
Comparable Survival of Treatment Naïve TP53 Mutated Acute Myeloid Leukemia Treated with Hypomethylating Agent Compared to Hypomethylating Agent Plus Venetoclax Based Therapy ash.confex.com/ash/2023/webp… #ASH23
2
2
10
13,217
This episode of #HealthcareUnfiltered podcast the week of ⁦@ASH_hematology⁩ #ASH23 is W the inspiring ⁦@ARosenthalDO⁩ of ⁦@MayoClinic⁩ talking caring for AYA pts w cancer. Alison who survived cancer shares all. Here’s the link & a clip: podcasts.apple.com/us/podcas…
1
7
2
16
5,214
People who enjoy meetings should not be in charge of anything.
79
1,285
109
7,494
323,069
Med students should be banned from participating in research
What unpopular academia opinion would get you in this situation?
141
591
215
7,140
1,903,479
Another extremely useful trial suggesting CODOX-M/IVAC is no better than da-EPOCH-R for Burkitt lymphoma without CNS dx.
New: Final results from the phase 3 HOVON/SAKK trial, comparing R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma thelancet.com/journals/lanha…
2
3
11
5,395
If I am presenting at #ASH23 but don't Tweet about it, does it count?
3
18
3,159
Not surprising when "success" is equated with seeing less patients
3
1
28
7,283
Replying to @UNMCHemeOnc
@UNMCHemeOnc @UNMCCOM @unmc @NebraskaMed celebrating #40th year transplant #BMT anniversary! The one and only Prof. James O. Armitage sharing the history and word of wisdom!
2
7
32
2,454
Talal Hilal 🩺 retweeted
This is an EXTREMELY important point. also Those with Visas D.Os if you are going to discriminate, at least dont make people waste their money
Hot take: programs that are not open to IMGs simply due to IMG status should disclose it prior to collecting that ERAS payment
2
22
1
308
68,418
PSA: if there are blasts on smear, there is no need to wait for MRD result
2
7
2,990
Talal Hilal 🩺 retweeted
Just being our nerdy haematologist selves @ASH_hematology @THilalMD
1
25
2,466
Great meeting and setting for #iwCLL2023. Thank you to the organizers for such a well planned workshop @MayoCancerCare
1
704
It’s pretty badass to have a separate division of Myeloma that is distinct from the division of Hematology @SylvesterCancer
3
1
1,705